QualifyHQ Logo

Enso

ENYO Pharma is a clinical-stage biopharmaceutical company developing innovative therapeutics based on fibrolytic and anti-inflammatory properties for diseases with impaired kidney function.The company is conducting Phase 2 trials with its lead compound Vonafexor in Chronic Kidney Diseases (CKD) and rare kidney disease such as Alport syndrome.

Grundlagt

2014

Omsætning

$2.5M - $5.0M

Finansiering

$108.8M

Se lignende virksomheder

Qualify this Company in

minutes

Mens andre værktøjer spilder din tid, hjælper vi dig med at kvalificere virksomheder, der passer bedre, på få minutter - så din pipeline forbliver sund, dit team forbliver produktivt, og dine handler bevæger sig hurtigere.

Start free trial

Start 7-dages gratis prøveperiode